Navigation Links
Fingolimod: 'Hint' of advantages in a small group of patients
Date:7/5/2012

This release is available in German.

The immunosuppressive drug fingolimod (trade name: Gilenya) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.

According to the findings of the assessment, patients with a rapidly progressive and severe course of disease who take fingolimod experience fewer flu-like symptoms. Under consideration of this advantage on the one hand and the uncertain evidence base on the other, IQWIG has concluded that the data provide a "hint" of a minor added benefit of fingolimod for this group of patients.

Due to a lack of evaluable data, an added benefit is not proven for two further groups of patients.

Separate assessment in three groups of patients

According to the different areas of application, IQWiG performed separate assessments of the drug in three groups of patients. Fingolimod was compared with glatiramer acetate in patients with highly active RRMS who had not responded to a complete and appropriate (usually at least one-year) cycle with beta-interferon (IFN-β).

In patients with highly active RRMS who had not received sufficient IFN-β therapy and in those with rapidly progressive severe RRMS, fingolimod was in each case compared with IFN-β 1a.

Evaluable data only for one group of patients

One relevant study was available for the early benefit assessment, an approval study on fingolimod (TRANSFORMS), which compared treatment with fingolimod versus IFN β 1a in adults with RRMS. However, the study only provide
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study supports urate protection against Parkinsons disease, hints at novel mechanism
2. Early Study Hints at Link Between Certain Sunscreens, Endometriosis
3. Mouse Study Hints at New Path for Diabetes Treatment
4. PawnUp.com Online Pawn Shop Spreads Awareness About its Small Business Loans.
5. Small Babies Can Be Sign of Heart Problems in Mother
6. Smallest, Largest Fetuses at Higher Risk of Stillbirth
7. Standing at Work All Day While Pregnant Linked to Smaller Babies
8. Google Rolls Out Another Panda Algorithm Update – Small Businesses Plan for the Future of SEO
9. B2B e Trader is Addressing the Critical Needs of Local Businesses by Lauching the New Shop Small Business Directory
10. Blood test for pregnant women could predict risk of having dangerously small babies
11. Infants cant distinguish between large and small groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... , ... August 01, 2015 , ... On Tuesday, July ... , who are thought to have been behind the attack on Anthem Inc. which ... were zero day exploits, watering hole attacks and spear phishing campaigns. , ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... High Times magazine. What are the STASH awards? The Significant Technological Achievements ... by the cannabis-cultivation community as well as tried-and-true products that have stood the ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... Ticket ... which is currently going on in Chicago at Grant Park. The festival will ... corner of North America to Chicago for the annual Lollapalooza. This unique and ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the ... new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round ... MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands of ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... HI---As school buses drive down the gravel roads in Dunn ... clouds of dust left in their wake contain such high ... the air every day are at an increased risk of ... the lungs, new research shows. Erionite is a natural mineral ...
... Laws, a second-year student in the master of social work ... Social Work (GCSW), is one of five outstanding graduate students ... for Mental Health. "Ana Luisa Laws clearly is ... ever had in the University of Houston Graduate College of ...
... News) -- Children and teens with abnormal development of the ... sports, such as soccer and basketball, are at greater risk ... Swiss researchers explained that deformities of the top of ... reduced rotation and pain during movement among young competitive athletes. ...
... Is it possible to predict whether someone is likely ... A new study by researchers at Wake Forest Baptist ... people, the first heart attack is more likely to be ... of the Epidemiological Cardiology Research Center (EPICARE) at Wake Forest ...
... a picture of many trees, young people will tend to say: ... likely we are to notice a single tree before seeing the ... the bigger picture is slower in older people. In a new ... researchers have found that these age-related changes are correlated with a ...
... SUNDAY, July 24 (HealthDay News) -- For patients suffering chest ... therapy may result in severe bleeding without reducing the risk ... A trial evaluating the combination treatment was halted early when ... became apparent. "It is very clear there is an ...
Cached Medicine News:Health News:New study finds cancer-causing mineral in US road gravel 2Health News:New study finds cancer-causing mineral in US road gravel 3Health News:University of Houston student awarded Hogg Foundation Scholarship 2Health News:Predictors of dying suddenly versus surviving heart attack identified 2Health News:Older people find it harder to see the wood for the trees 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 3
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... July 30, 2015 Tianyin Pharmaceutical Inc. (NYSE ... that specializes in the patented biopharmaceutical, modernized traditional Chinese ... provided updates regarding the notice it received on May ... indicating that the Company was below certain of the ... 134 and 1101 of the NYSE MKT Company Guide, ...
(Date:7/30/2015)... , July 30, 2015 Future ... report titled, "Continuous Glucose Monitoring Systems Market: Global Industry ... the report, the global continuous glucose monitoring systems market ... is expected to reach US$ 788.4 Mn by 2020, ... 2015 to 2020. Global continuous glucose monitoring ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... June 2 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheets: ... botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China ... 9:00 a.m. Eastern Time on Tuesday,June 8, 2010 ... its,fiscal year 2010, ended April 30, 2010 . , ...
... UNION CITY, Calif. , June 2 Questcor Pharmaceuticals, ... the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 ... Don M. Bailey , President and Chief Executive Officer, will discuss the ... . , , , ...
Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 3Questcor to Present at the Jefferies 2010 Global Life Sciences Conference 2
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
... The InVance Male Sling System is an ... mild to moderate stress urinary incontinence in ... solution for men who are not candidates ... limited manual dexterity, limited mental capacity or ...
Medicine Products: